SMN1 and proximal spinal muscular atrophy: To specifically assess its neuroprotective effect in the SMA context, we used the transgenic model where smn-1 is specifically silenced only in 19 D-type MNs27, thus avoiding the pleiotropic effect of smn-1 depletion in all the organism (that on the contrary occurs in SMA patients).